1. Home
  2. WCN vs IQV Comparison

WCN vs IQV Comparison

Compare WCN & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waste Connections Inc.

WCN

Waste Connections Inc.

HOLD

Current Price

$171.18

Market Cap

42.8B

Sector

Utilities

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$211.63

Market Cap

35.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WCN
IQV
Founded
1997
1982
Country
Canada
United States
Employees
N/A
93000
Industry
Power Generation
Biotechnology: Commercial Physical & Biological Resarch
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.8B
35.1B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
WCN
IQV
Price
$171.18
$211.63
Analyst Decision
Buy
Strong Buy
Analyst Count
19
16
Target Price
$204.21
$227.13
AVG Volume (30 Days)
1.2M
1.1M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
0.85%
N/A
EPS Growth
74.48
4.67
EPS
2.02
1.61
Revenue
$9,466,915,000.00
$9,739,000,000.00
Revenue This Year
$6.14
$6.77
Revenue Next Year
$6.18
$5.89
P/E Ratio
$83.97
$129.22
Revenue Growth
6.14
41.60
52 Week Low
$146.89
$154.50
52 Week High
$191.91
$247.05

Technical Indicators

Market Signals
Indicator
WCN
IQV
Relative Strength Index (RSI) 57.02 61.60
Support Level $168.34 $206.72
Resistance Level $173.26 $212.36
Average True Range (ATR) 3.08 5.45
MACD -0.66 -0.85
Stochastic Oscillator 33.13 55.19

Price Performance

Historical Comparison
WCN
IQV

About WCN Waste Connections Inc.

Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: